You have 9 free searches left this month | for more free features.

PET-MF

Showing 1 - 25 of 4,962

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Myelofibrosis (PMF), Post Polycythemia Myelofibrosis (PPV MF), Thrombocythemia Myelofibrosis (PET-MF) Trial

Available
  • Primary Myelofibrosis (PMF)
  • +2 more
  • (no location specified)
Jan 18, 2022

Myelofibrosis Trial in Worldwide (Ruxolitinib)

Completed
  • Myelofibrosis
  • Winter Park, Florida
  • +17 more
Jan 10, 2022

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

MPN (Myeloproliferative Tumors) Trial in Australia, Canada, United States (itacitinib)

Completed
  • MPN (Myeloproliferative Neoplasms)
  • Birmingham, Alabama
  • +21 more
Aug 25, 2021

Myelofibrosis Trial in Worldwide (INC424, BKM120)

Terminated
  • Myelofibrosis
  • Herston, Queensland, Australia
  • +14 more
Dec 16, 2020

Ammonia N-13 Myocardial Blood Flow Absolute Quantification by

Recruiting
  • Myocardial Ischemia
  • +7 more
  • Myocardial Perfusion Imaging Study
  • AMMONIA N-13 37.5 mCi in 1 mL INTRAVENOUS INJECTION [Ammonia N 13]
  • Miami, Florida
  • +3 more
Jan 4, 2023

Serial PET MPI in Patients Undergoing Cancer Treatment

Enrolling by invitation
  • Cancer
  • +3 more
    • Los Angeles, California
      West Los Angeles VA Medical Center
    Jun 12, 2023

    Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

    Completed
    • Myelofibrosis
    • VIC, Melbourne, Australia
    • +8 more
    Feb 7, 2022

    CNS Lymphoma Trial (68Ga-PTF)

    Recruiting
    • CNS Lymphoma
    • Aalborg, Denmark
    • +1 more
    Jan 17, 2023

    Normal Healthy Volunteers Without Chronic Medical Conditions, Coronary Artery Disease, Cardiac Risk Factors Trial in New Orleans

    Completed
    • Normal Healthy Volunteers Without Chronic Medical Conditions
    • +3 more
    • Slow Infusion of Rubidium-82
    • New Orleans, Louisiana
      Ochsner
    Jan 16, 2023

    Relapsed or Refractory CD30+ Malignancies When Re-treated With

    Completed
    • Hodgkin Disease
    • Lymphoma, T-Cell, Cutaneous
    • No Intervention
    • San Bartolome, Alicante, Spain
    • +29 more
    Jul 28, 2022

    Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Birmingham, Alabama
    • +151 more
    Aug 22, 2022

    Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

    Recruiting
    • Schizophrenia
    • +2 more
    • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Sep 16, 2022

    Ruxolitinib in Patients With Myelofibrosis

    Not yet recruiting
    • Myelofibrosis
    • (no location specified)
    Feb 28, 2023

    Long-term Evaluation

    Recruiting
    • Atherosclerosis
    • +3 more
    • PET imaging
    • +2 more
    • Cambridge, United Kingdom
      University of Cambridge
    Mar 18, 2022

    Sex and Obesity: Effects on Heart Failure Study

    Active, not recruiting
    • Obesity
    • Heart Failure
    • PET (positron Emission Tomography)
    • +7 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 30, 2023

    Different Sonographic Modalities and PET-CT in Pediatric

    Not yet recruiting
    • Pediatric Lymphoma
    • ultrasonography
    • (no location specified)
    Apr 22, 2022

    Response to Gemcitabine Chemotherapy in Mycosis Fungoides

    Recruiting
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides
    • single-arm, non-randomized Biodynamic imaging (BDI)
    • Indianapolis, Indiana
      Indiana University School of Medicine, Department of Dermatology
    Nov 16, 2022

    Inpatient Evaluation of Adults With Schizophrenia

    Recruiting
    • Schizophrenia
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

    Withdrawn
    • Primary Myelofibrosis
    • +4 more
    • (no location specified)
    Mar 2, 2021

    High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))

    Recruiting
    • High Grade Glioma
    • +12 more
    • LUTATHERA® (Lutetium Lu 177 dotatate)
    • Aurora, Colorado
    • +8 more
    Jan 16, 2023

    Assess the Safety of Fedratinib in Korean Myelofibrosis

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Seoul, Korea, Republic of
      Bristol-Myers Squibb YH
    Oct 3, 2023

    Imaging Tumor Hypoxia With 18F-EF5 PET in Recurrent or

    Terminated
    • Ovarian Cancer
    • Ovarian Neoplasms
    • 18F-EF5 PET/CT scan
    • Optional biopsy
    • Vancouver, British Columbia, Canada
      BC Cancer Agency - Vancouver Centre
    Feb 2, 2022